CG Oncology, Inc.
CGON
$20.64
$0.422.08%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -88.04M | -72.80M | -52.39M | -- | -- |
| Total Depreciation and Amortization | 32.00K | 36.00K | 15.00K | -- | -- |
| Total Amortization of Deferred Charges | -- | -9.00K | -9.00K | -- | -- |
| Total Other Non-Cash Items | 6.39M | -522.00K | -1.59M | -- | -- |
| Change in Net Operating Assets | 2.91M | 595.00K | -2.81M | -- | -- |
| Cash from Operations | -78.71M | -72.70M | -56.78M | -- | -- |
| Capital Expenditure | -234.00K | -25.00K | -26.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -300.53M | -296.11M | -328.11M | -- | -- |
| Cash from Investing | -300.76M | -296.14M | -328.14M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -365.00K | -372.00K | -372.00K | -- | -- |
| Issuance of Common Stock | 632.07M | 408.92M | 406.75M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 410.00K | 410.00K | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.42M | -6.99M | -6.99M | -- | -- |
| Cash from Financing | 628.28M | 401.97M | 399.80M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 248.80M | 33.14M | 14.89M | -- | -- |